P W. Intven

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Stereotactic body radiotherapy in early-stage hepatocellular carcinoma: a systematic review and meta-analysis.

Stereotactic body radiotherapy in early-stage hepatocellular carcinoma: a systematic review and meta-analysis.

Journal: ESMO gastrointestinal oncology
Published: April 17, 2026

Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial.

Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial.

Journal: Clinical and translational radiation oncology
Published: March 19, 2026

A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trial.

A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trial.

Journal: BMC cancer
Published: March 16, 2026

The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localized pancreatic cancer: A nationwide analysis.

The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localized pancreatic cancer: A nationwide analysis.

Journal: European journal of cancer (Oxford, England : 1990)
Published: February 24, 2026

Outcomes after (chemo)radiotherapy for anal cancer - A nationwide cohort study.

Outcomes after (chemo)radiotherapy for anal cancer - A nationwide cohort study.

Journal: Clinical and translational radiation oncology
Published: February 09, 2026

Patient-reported quality of life after chemoradiotherapy in patients with non-metastatic anal squamous cell carcinoma: A cross-sectional cohort study.

Patient-reported quality of life after chemoradiotherapy in patients with non-metastatic anal squamous cell carcinoma: A cross-sectional cohort study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 25, 2025

Timing of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: A nationwide analysis.

Timing of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: A nationwide analysis.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: August 20, 2025

First Patient Study with Visual Biofeedback for Gating Delivery Efficiency Improvements on a 1.5 T MR-linac: Biofeedback for MR-linac Gating: Patient Study.

First Patient Study with Visual Biofeedback for Gating Delivery Efficiency Improvements on a 1.5 T MR-linac: Biofeedback for MR-linac Gating: Patient Study.

Journal: International journal of radiation oncology, biology, physics
Published: March 03, 2025

Treatment time and learning curve analysis of 1.5 T MR-Linac workflows led by radiation oncologists or therapists.

Treatment time and learning curve analysis of 1.5 T MR-Linac workflows led by radiation oncologists or therapists.

Journal: Clinical and translational radiation oncology
Published: August 02, 2024

Correction: Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design.

Correction: Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design.

Journal: Trials
Published: July 05, 2024

Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design.

Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design.

Journal: Trials
Published: March 20, 2024

Prediction of Isolated Local Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Study.

Prediction of Isolated Local Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Study.

Journal: Annals of surgical oncology
Published: January 26, 2024
Showing 1-12 of 26

Last Updated: 09/26/2026